Last updated on November 2018

A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531


Brief description of study

This sponsor-open, investigator- and participant-blinded, multi-center study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of RO7020531 in healthy participants and in participants with chronic hepatitis B. Part I will be conducted in two portions: Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) which will include only healthy volunteers. Part II will commence after completion of the MAD portion of Part I and will include only Chronic Hepatitis B (CHB) participants.

Clinical Study Identifier: NCT02956850

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: NP39305 ...

King Chulalongkorn Memorial Hospital
Bangkok, Thailand
  Connect »

Reference Study ID Number: NP39305 ...

Siriraj Hospital
Bangkok, Thailand
4.55miles
  Connect »